We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.51B
AUM Growth
-$82.4M
(-3.2%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
22.43%
Holding
1,530
New
76
Increased
658
Reduced
739
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$7.07M |
| 2 |
Apple
AAPL
|
+$6.69M |
| 3 |
Microsoft
MSFT
|
+$5.81M |
| 4 |
Mettler-Toledo International
MTD
|
+$5.03M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$7.83M |
| 2 |
DuPont de Nemours
DD
|
+$6.5M |
| 3 |
AbbVie
ABBV
|
+$5.98M |
| 4 |
CELG
Celgene Corp
CELG
|
+$3.68M |
| 5 |
Netflix
NFLX
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.5% |
| 2 | Healthcare | 18.58% |
| 3 | Financials | 10.77% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.58% |
Similar funds
MASUI
XL
MSL
CA
APSPRSPT
TAM
NCM
GC
Profund Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Profund Advisors held 1,530 positions worth $2.51B, down 3.2% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Profund Advisors withdrew a net $100M in Q1 2018, closing 53 positions and reducing 739 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $2.76M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Profund Advisors opened a new position in Okta worth $1.55M.
- Profund Advisors's largest Q1 2018 buy was Okta: 38,807 shares worth $1.55M.
- Profund Advisors added most to Agilent Technologies in Q1 2018, an estimated $7.07M increase.
- Profund Advisors's biggest Q1 2018 reduction was Amgen, cutting an estimated $7.83M.
- Profund Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.76M.
- Profund Advisors's ten largest holdings make up 22% of its $2.51B portfolio in Q1 2018.
- Profund Advisors opened 76 new positions and closed 53 in Q1 2018.
- Profund Advisors's portfolio value fell 3.2% quarter-over-quarter to $2.51B.
Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.